Group I

No. = 117

Group II

No. = 199

Test value

p-value

Sig.

Hypertension

Negative

Positive

NA

36 (30.8%)

81 (69.2%)

0 (%)

170 (85.4%)

24 (12.1%)

5 (2.5%)

105.511

0.000

HS

Comorbidities other than hypertension

Present

Absent

NA

39 (33.3%)

78 (66.7%)

0 (0%)

21 (10.6%)

162 (81.4%)

16 (8 %)

21.311

0.000

HS

Type of the surgery performed

MRM

BCS

SCM

NA

64 (54.7%)

43 (36.8%)

0 (0%)

10 (8.5)

96 (48.2%)

86 (43.2%)

4 (2.1%)

13 (6.5%)

5.254

0.072

NS

Pathology

IDC

ILC

other

100 (85.5%)

10 (8.5%)

7 (6%)

172 (86.5%)

17 (8.5%)

10 (5%)

5.254

0.072

NS

Grade

1

0 (0.0%)

1 (0.5%)

2.117

0.347

NS

2

98 (83.8%)

176 (88.4%)

3

19 (16.2%)

22 (11.1%)

T stage

<2 cm

2 - 5 cm

5 cm and more

NA

20 (17.1%)

63 (53.9%)

28 (23.9%)

6 (5.1%)

36 (18.1%)

112 (56.3%)

44 (22.1%)

7 (3.5%)

7.172

0.127

NS

N stage

0

From 1 - 3 LNs

More than 3 LNs

NA

24 (20.5%)

41 (35.1%)

44 (37.6%)

8 (6.8%)

61 (30.7%)

66 (33.2%)

63 (31.6%)

9 (4.5%)

4.138

0.247

NS

LVI

Negative

Positive

NA

35 (29.9%)

25 (21.4%)

57 (48.7%)

71 (35.7%)

40 (20.1%)

88 (44.2%)

0.524

0.469

NS

Inflammatory manifestations

Negative

positive

NA

101 (86.3%)

14 (12%)

2 (1.7%)

164 (82.4%)

18 (9.1%)

17 (8.5%)

0.382

0.536

NS

Extracapsular extension

Negative

Positive

NA

39 (33.3%)

18 (15.4%)

60 (51.3%)

63 (31.7%)

48 (24.1%)

88 (44.2%)

2.148

0.143

NS

Multiplicity

Negative

Positive

NA

86 (73.5%)

24 (20.5%)

7 (6%)

167 (84 %)

21 (10.5%)

11 (5.5%)

6.137*

0.013

S